Quarterly report pursuant to Section 13 or 15(d)

Financial Information Relating to Reportable Segments (Detail)

v2.4.0.6
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Segment Reporting Information [Line Items]    
External sales $ 75,025 $ 77,596
Earnings before income taxes 37,986 40,500
Biotechnology
   
Segment Reporting Information [Line Items]    
External sales 69,503 72,303
Earnings before income taxes 36,994 39,984
Hematology
   
Segment Reporting Information [Line Items]    
External sales 5,522 5,293
Earnings before income taxes 2,103 1,918
Reportable Segment
   
Segment Reporting Information [Line Items]    
Earnings before income taxes 39,097 41,902
Unallocated Amount to Segment
   
Segment Reporting Information [Line Items]    
Earnings before income taxes $ (1,111) $ (1,402)